The Safety Profile of Ticagrelor among Older Adults (Age ≥75 years): A Pharmacovigilance Analysis
Cardiology · 09.06.2026 · 1-9
DOI: 10.1159/000552641 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology, online erschienen am 09.06.2026. Verfasst von Inbar Yacoby-Halevi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel, inbaryacoby@mail.tau.ac.il. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Introduction
Ticagrelor is a widely used potent P2Y12 inhibitor in patients aged ≥75 years with acute coronary syndromes. Despite its widespread use, data on ticagrelor’s safety in older adults remain limited.
Methods
We performed a retrospective pharmacovigilance analysis using the FDA Adverse Event Reporting System from 2010 to 2024. Disproportionality analysis compared ticagrelor with clopidogrel, assessing predefined adverse events in adults (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel, inbaryacoby@mail.tau.ac.il.
- Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel.
- Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
- Division of Cardiology, Department of Medicine, Columbia University, New York, New York, USA.
Zitieren
APA
Yacoby-Halevi, I., Kruchin, B., Gadot, C., Guz, D., Rotmensh, A., Shaleve, Y., Sharon, H., Greenberg, N., Fishman, B., Itelman, E., Rotholz, A., Skalsky, K., Orvin, K., Eisen, A., Kornowski, R., Lerman, T. T., & Levi, A. (2026). The Safety Profile of Ticagrelor among Older Adults (Age ≥75 years): A Pharmacovigilance Analysis. Cardiology, 1-9. https://doi.org/10.1159/000552641
Vancouver
Yacoby-Halevi I, Kruchin B, Gadot C, Guz D, Rotmensh A, Shaleve Y, et al. The Safety Profile of Ticagrelor among Older Adults (Age ≥75 years): A Pharmacovigilance Analysis. Cardiology. 2026:1-9. doi:10.1159/000552641
BibTeX
@article{YacobyHalevi2026,
author = {Yacoby-Halevi, Inbar and Kruchin, Boris and Gadot, Chen and Guz, Dmitri and Rotmensh, Assaf and Shaleve, Yonatan and Sharon, Hila and Greenberg, Noam and Fishman, Boris and Itelman, Edward and Rotholz, Aviad and Skalsky, Keren and Orvin, Katia and Eisen, Alon and Kornowski, Ran and Lerman, Tsahi T and Levi, Amos},
title = {The Safety Profile of Ticagrelor among Older Adults (Age ≥75 years): A Pharmacovigilance Analysis},
journal = {Cardiology},
year = {2026},
pages = {1--9},
doi = {10.1159/000552641}
}
EUVIMED